Bone Drug Lowers Risk of Breast Cancer Recurrence | HealthDay | Find ...
A drug used to treat osteoporosis lowered the risk of breast cancer recurrence in premenopausal women with early breast cancer.
Featured Articles
Teva Receives FDA Approval Of Trazo...
JERUSALEM, Israel--(BUSINESS WIRE)--May 1, 1997--Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVIY) today announced t...
AMGEN PROFITS UP SHARPLY ANTI-ANEMI...
Byline: Evan Pondel Staff Writer THOUSAND OAKS - Amgen Inc. saw its second-quarter profit jump more than 47 percent ...
A proposed protocol for monitoring ...
AbstractNo widely accepted protocol or guideline exists for monitoring ototoxicity in patients who take powerful and ...
Retapamulin 1% topical ointment for...
Retapamulin (Altabax) 1% ointment is a topical antibiotic labeled for use in adults and children older than nine month...
FDA Grants Full Approval for DepoCy...
BRIDGEWATER, N.J. -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that the US Food and Drug Administr...